Compare FTK & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTK | INMD |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 720.7M | 842.0M |
| IPO Year | 1997 | 2018 |
| Metric | FTK | INMD |
|---|---|---|
| Price | $24.11 | $13.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $20.00 | $17.33 |
| AVG Volume (30 Days) | 323.4K | ★ 820.8K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.06 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $136,092,000.00 | N/A |
| Revenue This Year | $13.33 | $1.74 |
| Revenue Next Year | $16.38 | $3.26 |
| P/E Ratio | $196.25 | ★ $10.11 |
| Revenue Growth | ★ 214.53 | N/A |
| 52 Week Low | $10.96 | $12.72 |
| 52 Week High | $25.54 | $16.74 |
| Indicator | FTK | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.72 | 42.25 |
| Support Level | $15.01 | $13.27 |
| Resistance Level | N/A | $13.87 |
| Average True Range (ATR) | 1.54 | 0.26 |
| MACD | 0.29 | -0.03 |
| Stochastic Oscillator | 76.71 | 24.73 |
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.